carboplatin
Showing 26 - 50 of 1,824
Breast Cancer Trial in Shenyang (Pyrotinib, Trastuzumab, Dalpiciclib)
Not yet recruiting
- Breast Cancer
- Pyrotinib
- +7 more
-
Shenyang, Liaoning, ChinaShengjing Hospital of China Medical University
Dec 2, 2022
Breast Cancer Trial in Houston (Panitumumab, Nab-paclitaxel, Carboplatin)
Completed
- Breast Cancer
- Panitumumab
- +5 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Sep 20, 2022
Breast Cancer Trial in United States (carboplatin, paclitaxel albumin-stabilized nanoparticle formulation, vorinostat)
Active, not recruiting
- Breast Cancer
- carboplatin
- +3 more
-
Birmingham, Alabama
- +4 more
Feb 1, 2023
NSCLC Trial in Boston, New York (MPDL3280A, Carboplatin, Nab-paclitaxel)
Completed
- Carcinoma, Non-Small-Cell Lung
- MPDL3280A
- +2 more
-
Boston, Massachusetts
- +1 more
Oct 12, 2022
Hormone Receptor Positive HER-2 Negative Breast Cancer Trial in Shanghai (Docetaxel, Carboplatin, Epirubicin)
Recruiting
- Hormone Receptor Positive HER-2 Negative Breast Cancer
- Docetaxel
- +3 more
-
Shanghai, Shanghai, ChinaBreast cancer institute of Fudan University Cancer Hospital
Jun 12, 2023
Carcinoma, Non-Small-Cell Lung Trial in Beijing (HLX10, an engineered anti-PD-1 antibody, HLX04, a bevacizumab biosimilar,
Recruiting
- Carcinoma
- Non-Small-Cell Lung
- HLX10, an engineered anti-PD-1 antibody
- +3 more
-
Beijing, Beijing, ChinaCancer Hospital Chinese Academy of Medical Sciences (CAMS)
Apr 29, 2022
Adenocarcinoma of Lung, NSCLC Trial in Rolling Meadows (LP-300, Pemetrexed, Carboplatin)
Not yet recruiting
- Adenocarcinoma of Lung
- Carcinoma, Non-Small-Cell Lung
- LP-300
- +2 more
- (no location specified)
Jul 8, 2022
Non Small Cell Lung Cancer Trial in Scottsdale, Rochester (Proton Beam Therapy, Carboplatin, Paclitaxel)
Recruiting
- Non Small Cell Lung Cancer
- Proton Beam Therapy
- +2 more
-
Scottsdale, Arizona
- +1 more
Nov 9, 2022
Prostate Cancer Aggressiveness, Prostate Carcinoma Trial in Houston (Cabazitaxel, Carboplatin, Prednisone 5Mg)
Active, not recruiting
- Prostate Cancer Aggressiveness
- Prostate Carcinoma
- Cabazitaxel
- +3 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Dec 5, 2022
Extensive-stage Small-cell Lung Cancer Trial in China (serplulimab, Cisplatin, Carboplatin)
Not yet recruiting
- Extensive-stage Small-cell Lung Cancer
- serplulimab
- +4 more
-
Shantou, Guangdong, China
- +6 more
Mar 1, 2023
Gynecologic Malignancies Trial in Cleveland (Paclitaxel, Carboplatin)
Terminated
- Gynecologic Malignancies
- Paclitaxel
- Carboplatin
-
Cleveland, OhioCleveland Clinic Taussig Cancer institute, Case Comprehensive Ca
Jun 29, 2022
Ovarian Cancer, Chemotherapeutic Toxicity Trial in Evanston (Fasting Mimicking Diet (Xentigen by L'Nutra), Carboplatin,
Not yet recruiting
- Ovarian Cancer
- Chemotherapeutic Toxicity
- Fasting Mimicking Diet (Xentigen by L'Nutra)
- +3 more
-
Evanston, IllinoisNorthShore University HealthSystem
Jun 25, 2023
Head Neck Cancer, Head and Neck Tumors, Squamous Cell Carcinoma of Head and Neck Trial in Chicago (Xevinapant, Carboplatin,
Not yet recruiting
- Head and Neck Cancer
- +2 more
- Xevinapant
- +3 more
-
Chicago, IllinoisUniversity of Chicago Medicine Comprehensive Cancer Center
Oct 25, 2023
Lung Cancer Trial in Houston (AMG 510, Cisplatin, Carboplatin)
Recruiting
- Lung Cancer
- AMG 510
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Oct 10, 2022
NSCLC, Squamous Cell Carcinoma Trial in Wuhan (Nab-paclitaxel, Carboplatin, Thoracic radiation therapy)
Terminated
- Carcinoma, Non-Small-Cell Lung
- Squamous Cell Carcinoma
- Nab-paclitaxel
- +2 more
-
Wuhan, Hubei, ChinaZhongnan Hospital of Wuhan University
Apr 26, 2022
Large Cell Neuroendocrine Carcinoma of the Lung Trial in Athens (Atezolizumab, Carboplatin, Etoposide)
Completed
- Large Cell Neuroendocrine Carcinoma of the Lung
- Atezolizumab
- +2 more
-
Athens, Greece
- +1 more
Sep 16, 2023
Triple Negative Breast Cancer, Stage IV Breast Cancer, HER2 Negative Trial in United States (Atezolizumab, Carboplatin,
Active, not recruiting
- Triple Negative Breast Cancer
- +3 more
- Atezolizumab
- +3 more
-
Washington, District of Columbia
- +5 more
Dec 1, 2022
Untreated Advanced or Recurrent Thymic Carcinomas Trial in Chuo (MK-3475, Lenvatinib, Carboplatin)
Not yet recruiting
- Untreated Advanced or Recurrent Thymic Carcinomas
- MK-3475
- +3 more
-
Chuo, Tokyo, JapanNational Cancer Center Hospital
Apr 16, 2023
High Grade Ovarian Cancer, Primary Peritoneal Cancer, Fallopian Tube Cancer Trial (Mirvetuximab soravtansine, Carboplatin)
Not yet recruiting
- High Grade Ovarian Cancer
- +2 more
- Mirvetuximab soravtansine
- Carboplatin
- (no location specified)
Jul 11, 2022
Breast Tumor Trial in Shanghai (Decitabine, Carboplatin)
Terminated
- Breast Neoplasm
- Decitabine
- Carboplatin
-
Shanghai, Shanghai, ChinaRuijin Hospital, Shanghai Jiaotong University School of Medicine
Mar 28, 2022
Non-squamous Non-small-cell Lung Cancer, Brain Metastases Trial in Guangzhou (Camrelizumab, Pemetrexed, Carboplatin)
Active, not recruiting
- Non-squamous Non-small-cell Lung Cancer
- Brain Metastases
- Camrelizumab
- +2 more
-
Guangzhou, Guangzhou, ChinaLi-Kun Chen
Nov 13, 2022
Advanced Malignant Solid Tumor, Metastatic Malignant Solid Tumor, Unresectable Malignant Solid Tumor Trial in New Brunswick,
Active, not recruiting
- Advanced Malignant Solid Neoplasm
- +2 more
- Carboplatin
- +2 more
-
New Brunswick, New Jersey
- +2 more
Jun 28, 2022
Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Atypical Chronic Myeloid
Active, not recruiting
- Acute Myeloid Leukemia
- +9 more
- Carboplatin
- +3 more
-
Los Angeles, California
- +5 more
Jan 27, 2023
Ovarian Cancer, Relapsed Ovarian Cancer, Fallopian Tube Cancer Trial (Carboplatin)
Not yet recruiting
- Ovarian Cancer
- +6 more
- Carboplatin
- (no location specified)
Oct 27, 2022